Atossa Therapeutics, Inc.: Form 8-K, filed Oct 14, 2025
Filed with the SEC on Oct 14, 2025 and accepted by EDGAR at Oct 14, 2025, 11:50 ET.
Items reported
- Item 5.02 Departure or appointment of officers or directors
- Item 7.01 Regulation FD disclosure
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-25-238065. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.